R&I: Dermatophytosis Global Clinical Trials Review - Size, Share, Global Trends 2014 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

R&I: Dermatophytosis Global Clinical Trials Review - Size, Share, Global Trends 2014

Description:

GlobalData's clinical trial report, “Dermatophytosis Global Clinical Trials Review, H2, 2014" provides data on the Dermatophytosis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dermatophytosis. Detailed report at: – PowerPoint PPT presentation

Number of Views:31

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: R&I: Dermatophytosis Global Clinical Trials Review - Size, Share, Global Trends 2014


1

Dermatophytosis Global Clinical Trials Review,
H2, 2014

Publisher Global Data
No of pages 83
Publish Date Nov 2014
2
Description


GlobalData's clinical trial report,
Dermatophytosis Global Clinical Trials Review,
H2, 2014" provides data on the Dermatophytosis
clinical trial scenario. This report provides
elemental information and data relating to the
clinical trials on Dermatophytosis. It includes
an overview of the trial numbers and their
recruitment status as per the site of trial
conduction across the globe. The databook
offers a preliminary coverage of disease clinical
trials by their phase, trial status, prominence
of the sponsors and also provides briefing
pertaining to the number of trials for the key
drugs for treating Dermatophytosis. This report
is built using data and information sourced from
proprietary databases, primary and secondary
research and in-house analysis by GlobalData's
team of industry experts. Enquire about report
at http//www.reportsandintelligence.com/enquire-
about-report/153553
3
Scope

  • Data on the number of clinical trials conducted
    in North America, South and Central America,
    Europe, Middle-East and Africa and Asia-pacific
    and top five national contributions in each
  • Clinical trial (complete and in progress) data by
    phase, trial status, subjects recruited and
    sponsor type
  • Listings of discontinued trials (suspended,
    withdrawn and terminated)
  • Get all reports of Pharmaceutical category at
    http//www.reportsandintelligence.com/pharmaceutic
    als-market-report

4
Reasons to buy

  • Understand the dynamics of a particular
    indication in a condensed manner
  • Abridged view of the performance of the trials in
    terms of their status, recruitment, location,
    sponsor type and many more
  • Obtain discontinued trial listing for trials
    across the globe
  • Espy the commercial landscape of the major
    Universities / Institutes / Hospitals or
    Companies
  • View detailed report at http//www.reportsandinte
    lligence.com/dermatophytosis-global-clinical-trial
    s-review-h2-2014-market

5
Table Of Content


Table of Contents 2List of Tables 4List of
Figures 5Introduction 6Dermatophytosis 6Report
Guidance 6Clinical Trials by Region 7Clinical
Trials and Average Enrollment by Country 8Top
Five Countries Contributing to Clinical Trials in
Asia-Pacific 10Top Five Countries Contributing
to Clinical Trials in Europe 11Top Countries
Contributing to Clinical Trials in North America
12Top Countries Contributing to Clinical Trials
in Middle East and Africa 13Top Five Countries
Contributing to Clinical Trials in Central and
South America 14Clinical Trials by G7 Countries
Proportion of Dermatophytosis to Infectious
Disease Clinical Trials 15 Clinical Trials by
Phase in G7 Countries 16
6
Table Of Content


Clinical Trials in G7 Countries by Trial Status
17Clinical Trials by E7 Countries Proportion of
Dermatophytosis to Infectious Disease Clinical
Trials 18Clinical Trials by Phase in E7
Countries 19Clinical Trials in E7 Countries by
Trial Status 20Clinical Trials by Phase 21In
Progress Trials by Phase 22Clinical Trials by
Trial Status 23Clinical Trials by End Point
Status 24Unaccomplished Trials of
Dermatophytosis 25Subjects Recruited Over a
Period of Time 27Clinical Trials by Sponsor Type
28Prominent Sponsors 29Top Companies
Participating in Dermatophytosis Therapeutics
Clinical Trials 30Prominent Drugs 31Clinical
Trial Profiles 32Clinical Trial Overview of Top
Companies 32
7
Table Of Content


Merz Pharma GmbH Co. KgaA 32Clinical Trial
Overview of Merz Pharma GmbH Co. KgaA
32Valeant Pharmaceuticals International, Inc.
33Clinical Trial Overview of Valeant
Pharmaceuticals International, Inc. 33Sun
Pharmaceutical Industries Limited 34Clinical
Trial Overview of Sun Pharmaceutical Industries
Limited 34Novartis AG 35Clinical Trial Overview
of Novartis AG 35York Pharma Plc (Inactive)
36Clinical Trial Overview of York Pharma Plc
(Inactive) 36 Tinea Pharmaceuticals 37 Clinical
Trial Overview of Tinea Pharmaceuticals 37 Get
full TOC at http//www.reportsandintelligence.co
m/dermatophytosis-global-clinical-trials-review-h2
-2014-market/table-of-contents
8

FOR MORE DETAILS
Visit us at
http//www.reportsandintelligence.com/dermatophyto
sis-global-clinical-trials-review-h2-2014-market
Stay With Us
TELEPHONE Direct 1 (617) 674-4143 Toll Free
1 (855) 711-1555E-MAIL sales_at_reportsandintellig
ence.com
5933 NE Win Sivers Drive,205, Portland, OR
97220United States
About PowerShow.com